BYVASDA is an anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody and a bevacizumab biosimilar independently developed by Innovent Biologics... Dec 28
Antengene announces acceptance of IND application in China for ATG-010 (selinexor) in combination with R-GDP (SR-GDP) for the treatment of rrDLBCL in ... Dec 07
Joint venture expands global pharma services capacity for drug development and manufacturing ... Nov 06
The nasal spray vaccination could generate double protection for vaccine recipients - Influenza and the novel Coronavirus ... Sep 11
-Advertisements-